Novo Nordisk
NVO
#19
Rank
โ‚น41.688 T
Marketcap
โ‚น9,034
Share price
-1.86%
Change (1 day)
7.61%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น5.023 Trillion

According to Novo Nordisk's latest financial reports the company's total assets are โ‚น5.023 Trillion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚น3.877 T34.87%
2022-12-31โ‚น2.874 T30.43%
2021-12-31โ‚น2.204 T25.81%
2020-12-31โ‚น1.751 T30.45%
2019-12-31โ‚น1.343 T13.18%
2018-12-31โ‚น1.186 T12.63%
2017-12-31โ‚น1.053 T12.27%
2016-12-31โ‚น938.48 B4.97%
2015-12-31โ‚น894.00 B12.07%
2014-12-31โ‚น797.70 B-0.85%
2013-12-31โ‚น804.52 B26.19%
2012-12-31โ‚น637.55 B6.93%
2011-12-31โ‚น596.23 B21.42%
2010-12-31โ‚น491.03 B0.35%
2009-12-31โ‚น489.30 B6.87%
2008-12-31โ‚น457.84 B24.72%
2007-12-31โ‚น367.08 B4.58%
2006-12-31โ‚น351.01 B17.59%
2005-12-31โ‚น298.51 B0.45%
2004-12-31โ‚น297.19 B11.9%
2003-12-31โ‚น265.58 B22.46%
2002-12-31โ‚น216.86 B8.43%
2001-12-31โ‚น200.01 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น18.519 T 268.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.379 T 26.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.903 T 57.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.736 T 133.62%๐Ÿ‡ซ๐Ÿ‡ท France